Heparin-binding EGF-like Growth Factor Increases Intestinal Microvascular Blood Flow in Necrotizing Enterocolitis
Overview
Affiliations
Background & Aims: Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in neonates. Although the exact etiology remains unknown, decreased intestinal blood flow is believed to play a critical role. We have shown that heparin-binding epidermal growth factor-like growth factor (HB-EGF) protects the intestines from injury in a rodent model of NEC. Our current goal was to assess the effect of HB-EGF on intestinal microvascular blood flow and intestinal injury in rat pups subjected to experimental NEC.
Methods: Newborn rat pups were subjected to stress by exposure to hypoxia, hypothermia, hypertonic feedings, and lipopolysaccharide, with some pups receiving HB-EGF (800 microg x kg(-1) x dose(-1)) added to the feeds. Control animals received breast milk. Intestinal injury was graded using a standard histologic injury scoring system. Microvascular blood flow was assessed by fluorescein isothiocyanate/dextran angiography, with fluorescent images subjected to quantification, and by scanning electron microscopy.
Results: Intestinal microvascular blood flow (defined as the extent of vascular filling with fluorescein isothiocyanate/dextran) was significantly decreased in pups subjected to stress compared with breast-fed pups. Stressed pups treated with HB-EGF had significantly increased microvascular blood flow. The changes in villous microvasculature correlated with histologic injury scores, with stressed pups treated with HB-EGF showing decreased histologic injury.
Conclusions: HB-EGF significantly preserved intestinal microvascular blood flow in pups subjected to experimental NEC, indicating that HB-EGF may play a critical role in the treatment of various diseases manifested by decreased intestinal blood flow, including NEC.
Zhang D, Huang Z, Liu X, Ding X, Li L, He Y Pediatr Res. 2024; 97(1):128-137.
PMID: 39134757 DOI: 10.1038/s41390-024-03419-6.
Chen Z, Chen H, Huang W, Guo X, Yu L, Shan J Gut Microbes. 2024; 16(1):2379566.
PMID: 39013030 PMC: 11253882. DOI: 10.1080/19490976.2024.2379566.
miR-375-3p targets YWHAB to attenuate intestine injury in neonatal necrotizing enterocolitis.
Nan L, Kaisi F, Mengzhen Z, Yang Y, Jiaming Y, Huirong Y Pediatr Surg Int. 2024; 40(1):63.
PMID: 38431920 DOI: 10.1007/s00383-024-05653-9.
Necrotizing enterocolitis: recent advances in treatment with translational potential.
Ganji N, Li B, Lee C, Pierro A Pediatr Surg Int. 2023; 39(1):205.
PMID: 37247104 DOI: 10.1007/s00383-023-05476-0.
Zhang X, Zhang Y, He Y, Zhu X, Ai Q, Shi Y J Transl Med. 2023; 21(1):14.
PMID: 36627673 PMC: 9830848. DOI: 10.1186/s12967-022-03866-x.